[1]
“MOLECULAR BIOMARKERS AND HISTOLOGICAL PARAMETERS IMAPCT ON SURVIVAL AND RESPONSE TO FIRST- LINE SYSTEMIC THERAPY OF METASTATIC COLORECTAL CANCER PATIENTS”, Radiol Oncol, vol. 53, no. 1, Feb. 2019, Accessed: Nov. 21, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/3168